Literature DB >> 36192514

ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.

Daryl K A Chia1, Jia Jun Ang1, Raghav Sundar2,3,4, Guowei Kim1,3,5, Asim Shabbir1,3,5, Jimmy B Y So6,7,8, Wei Peng Yong2,9.   

Abstract

Entities:  

Year:  2022        PMID： 36192514     DOI： 10.1245/s10434-022-12102-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  4 in total

1.  Benefits of Surgery After Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients With Peritoneal Metastasis: A Meta-Analysis.

Authors:  Yingbo Gong; Pengliang Wang; Zhi Zhu; Junyan Zhang; Jinyu Huang; Tao Wang; Jisai Chen; Huimian Xu
Journal:  J Surg Res       Date:  2019-08-14       Impact factor: 2.192

2.  Reply to Z. Li et al.

Authors:  Hironori Ishigami
Journal:  J Clin Oncol       Date:  2018-11-26       Impact factor: 44.544

3.  Randomized Controlled Trial Investigating Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Grace Hwei Ching Tan; Claramae Shulyn Chia; Jolene Si Min Wong; Whee Sze Ong; Hong-Yuan Zhu; Chin-Ann Johnny Ong; Melissa Ching Ching Teo
Journal:  Ann Surg Oncol       Date:  2022-09-30       Impact factor: 4.339

Review 4.  Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.

Authors:  Yong Xiang Gwee; Daryl Kai Ann Chia; Jimmy So; Wim Ceelen; Wei Peng Yong; Patrick Tan; Chin-Ann Johnny Ong; Raghav Sundar
Journal:  J Clin Oncol       Date:  2022-06-01       Impact factor: 50.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.